Lilly Pulitzer on Oct. 1 launched its annual Print with a Purpose collection with the Breast Cancer Research Foundation, the company announced in a news release. As part of the campaign ...

Creator JJ Abrams struck gold with the hit series Lost, which premiered 20 years ago in September 2004, ushering in the era of 'water cooler' TV, which saw endless discussion about the latest ...

Singapore Cable Car offering $4 adult and $3 child Sentosa Line tickets for locals ...

A party and craft retailer is set to close even more stores, with liquidation sales offering up to 25 percent off. The closure of four Party City stores come after a difficult 2023 for the chain ...

Eli Lilly’s two weight loss drugs have become blockbusters, bringing in more than $1 billion in annual revenue. Demand is growing in this market, but so is competition. These players ...

Indian-origin Pulitzer Prize-winning author Jhumpa Lahiri, has declined the prestigious 2024 Isamu Noguchi Award in protest of the Noguchi Museum’s recently implemented dress code policy. Lahiri’s ...

Donanemab, manufactured by Eli Lilly (LLY), is the latest in a new class of anti-amyloid drugs that deliver antibodies to target beta-amyloid, a protein linked to Alzheimer's disease. Initially ...

The most recent trading session ended with Eli Lilly (LLY) standing at $909.32, reflecting a -1.65% shift from the previouse trading day's closing. This change lagged the S&P 500's daily gain of 0.4%.

Novo Nordisk and Eli Lilly are undoubtedly at the top of the weight loss market. With $1.7 billion in second-quarter sales recorded for Novo’s Wegovy and $1.2 billion for Lilly’s Zepbound, the ...

Sept 24 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing patients with another treatment ...